Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - kenneth shindler
Gene therapy for optic neuropathy
Problem: Optic neuritis is a condition commonly observed in MS patients that leads to temporary or permanent visual decline following demyelination of the optic nerve and loss of retinal ganglion cells. Current therapies for MS and ON include immunosuppressive agents that mitigate the inflammatory component of disease. Unfortunately, these treatments...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by